Subset analysis of patients experiencing clinical events of a potentially immunogenic nature in the pivotal clinical trials of tocilizumab for rheumatoid arthritis: Evaluation of an antidrug antibody ELISA using clinical adverse event-driven immunogenicity testing

Autor: Stubenrauch, Kay, Wessels, Uwe, Birnboeck, Herbert, Ramirez, Francisco, Jahreis, Angelika, Schleypen, Julia
Zdroj: In Clinical Therapeutics 2010 32(9):1597-1609
Databáze: ScienceDirect
Externí odkaz: